Toshio Miyata - Concepedia

Author

Toshio Miyata

Also Known As

Bahl Lee, Miyata Toshio, Miyata, Toshio, T MIYATA, T Miyata, T. Miyata, TOSHIO MIYATA, Tadaaki Miyata, Takatomi MIYATA, Tomohiko Miyata

456

Publications

22.9K

Citations

H-Index

235

Concepts

All Affiliations

Tokai University Tohoku University The University of Tokyo UCLouvain Nagoya University

About

Toshio Miyata is an author at Tokai University specializing in medicine, physiology, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	56	117	11K
2	Health Sciences	19	23	2.8K
3	Natural Sciences	9	9	1.1K
4	Engineering	3	3	100
5	Public Health	1	1	15

Toshio Miyata

227

Publications

19.3K

Citations

H-Index

Page 1

	Year	Citations
Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria Junji Takeda, Toshio Miyata, Kazuyoshi Kawagoe, Cell Somatic MutationGenetic DisorderGeneticsInherited Metabolic DiseaseHematology	1993	1K
Protein-bound acrolein: Potential markers for oxidative stress Kôji Uchida, Masamichi Kanematsu, Kensuke Sakai, Proceedings of the National Academy of Sciences InflammationRedox SignalingOxysterolBiochemistryAtherosclerosis	1998	625
The Cloning of PIG-A, a Component in the Early Step of GPI-Anchor Biosynthesis Toshio Miyata, Junji Takeda, Yoshiyasu Iida, Science	1993	534
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. Kyoji Horie, Toshio Miyata, Kenji Maeda, Journal of Clinical Investigation Glomerular DiseaseRenal PathologyGlycobiologyGlycoxidation ProductsLocal Oxidative Stress	1997	430
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. Toshio Miyata, Osamu Oda, Reiko Inagi, Journal of Clinical Investigation BiochemistryMajor ComponentMedicineAmyloid FibrilsBioanalysis	1993	404
Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. Monica Bessler, Philip J. Mason, Peter Hillmen, The EMBO Journal Somatic MutationsHeme HomeostasisGenetic DisorderGeneticsPhysiology	1994	401
Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. Toshio Miyata, Reiko Inagi, Yuichiro Iida, Journal of Clinical Investigation ImmunologyGlycobiologyPathologyNeuroinflammationInflammation	1994	343
Angiotensin II Receptor Antagonists and Angiotensin-Converting Enzyme Inhibitors Lower In Vitro the Formation of Advanced Glycation End Products Toshio Miyata, Charles van Ypersele de Strihou, Yasuhiko Ueda, Journal of the American Society of Nephrology	2002	291
The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. Toshio Miyata, Osamu Hori, Jian Zhang, Journal of Clinical Investigation ImmunologyGlycobiologyImmune RegulationCentral MediatorInflammation	1996	286
Immunohistochemical Evidence for an Increased Oxidative Stress and Carbonyl Modification of Proteins in Diabetic Glomerular Lesions Daisuke Suzuki, Toshio Miyata, Noboru Saotome, Journal of the American Society of Nephrology	1999	252

Page 1